For research and educational purposes only. Not medical advice.
Oxiracetam Reference
Educational, not medical advice reference for Oxiracetam: Nootropic, Cognitive; regulatory status, evidence posture, source review, and schedule notes. Also…
Reference summary
Italian dementia / cognitive-impairment trials exist; effect sizes are modest. No US approval.
- Categories
- Nootropic, Cognitive
- Aliases
- ISF-2522, CT-848
- Evidence posture
- human — Not FDA-approved in the US. Italian non-US approval; trial methodology and effect sizes are debated.
- Regulatory status
- No FDA-approved oxiracetam drug label. Approved in Italy and a few other non-US markets for cognitive impairment.
- Content review status
- research reference